Sulfadoxine [2447-57-6]
Referencia HY-B0439-500mg
embalaje : 500mg
Marca : MedChemExpress
Sulfadoxine(Sulphadoxine) is a long acting sulfonamide that is used, usually in combination with other agents, for respiratory, urinary tract and malarial infections. Sulfadoxine inhibits HIV replication in peripheral blood mononuclear cells.
Para uso exclusivo en investigación. No vendemos a pacientes.
Sulfadoxine Estructura química
No. CAS : 2447-57-6
This product is a controlled substance and not for sale in your territory.
Based on 1 publication(s) in Google Scholar
Other Forms of Sulfadoxine:
- Sulfadoxine-d4 Obtener un presupuesto
- Sulfadoxine-d3 Obtener un presupuesto
- Sulfadoxine (Standard) Obtener un presupuesto
Ver todos los productos específicos de isoformas Parasite:
Ver todos los productos específicos de isoformas HIV:
Ver todos los productos específicos de isoformas Antibiotic:
Descripciòn |
Sulfadoxine(Sulphadoxine) is a long acting sulfonamide that is used, usually in combination with other agents, for respiratory, urinary tract and malarial infections. Sulfadoxine inhibits HIV replication in peripheral blood mononuclear cells. |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||
In Vitro |
Sulfadoxine(Sulphadoxine) is an ultra-long-lasting sulfonamide. Sulfadoxine is often used in combination with pyrimethamine to treat or prevent malaria. Both drugs are antifolates; they inhibit the production of enzymes involved in the synthesis of folic acid within the parasites. Either drug by itself is only moderately effective in treating malaria, because the parasite Plasmodium falciparum may be able to use exogenous folic acid, i.e. folic acid which is present in the parasite's environment, while in combination, the two substances have a synergistic effect which outbalances that ability [1, 2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
Ensayo clínico |
|
||||||||||||
Peso molecular |
310.33 |
||||||||||||
Fòrmula |
C12H14N4O4S |
||||||||||||
No. CAS |
2447-57-6 |
||||||||||||
Appearance |
Solid |
||||||||||||
Color |
White to off-white |
||||||||||||
SMILES |
O=S(NC1=NC=NC(OC)=C1OC)(C2=CC=C(N)C=C2)=O |
||||||||||||
Structure Classification |
|
||||||||||||
Initial Source |
|
||||||||||||
Envío | Room temperature in continental US; may vary elsewhere. |
||||||||||||
Almacenamiento |
|
||||||||||||
Solvente y solubilidad |
In Vitro:
DMSO : ≥ 100 mg/mL (322.24 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol) Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2 In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
Dosage mg/kgAnimal weight Dosing volume Number of animals Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO
+
%
+
%
Tween-80
+
%
Saline
The co-solvents required include: DMSO,
. All of co-solvents are available by MedChemExpress (MCE).
, Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration:
mg/mL
Method for preparing stock solution:
mg
drug dissolved in
μL
DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take
μL DMSO stock solution, add
μL .
μL , mix evenly, next add
μL Tween 80, mix evenly, then add
μL Saline.
If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
|
||||||||||||
Pureza y Documentación |
Purity: 98.24% |
||||||||||||
Referencias |
|
Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
---|
DMSO | 1 mM | 3.2224 mL | 16.1119 mL | 32.2238 mL | 80.5594 mL |
5 mM | 0.6445 mL | 3.2224 mL | 6.4448 mL | 16.1119 mL | |
10 mM | 0.3222 mL | 1.6112 mL | 3.2224 mL | 8.0559 mL | |
15 mM | 0.2148 mL | 1.0741 mL | 2.1483 mL | 5.3706 mL | |
20 mM | 0.1611 mL | 0.8056 mL | 1.6112 mL | 4.0280 mL | |
25 mM | 0.1289 mL | 0.6445 mL | 1.2890 mL | 3.2224 mL | |
30 mM | 0.1074 mL | 0.5371 mL | 1.0741 mL | 2.6853 mL | |
40 mM | 0.0806 mL | 0.4028 mL | 0.8056 mL | 2.0140 mL | |
50 mM | 0.0644 mL | 0.3222 mL | 0.6445 mL | 1.6112 mL | |
60 mM | 0.0537 mL | 0.2685 mL | 0.5371 mL | 1.3427 mL | |
80 mM | 0.0403 mL | 0.2014 mL | 0.4028 mL | 1.0070 mL | |
100 mM | 0.0322 mL | 0.1611 mL | 0.3222 mL | 0.8056 mL |
Sulfadoxine Related Classifications
- Infection
- Anti-infection Metabolic Enzyme/Protease
- Parasite HIV Antibiotic Endogenous Metabolite